New Zealand markets closed

Tiziana Life Sciences PLC (0RP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.6800-0.0600 (-8.11%)
As of 08:02AM CET. Market open.
Full screen
Previous close0.7400
Bid0.6900 x N/A
Ask0.7150 x N/A
Day's range0.6800 - 0.6800
52-week range0.6800 - 4.1382
Avg. volume3
Market cap66.168M
Beta (5Y monthly)-0.02
PE ratio (TTM)N/A
EPS (TTM)-0.1950
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Tiziana Life Sciences to participate in a Fireside Chat At the B. Riley Securities 2022 Oncology Conference

    NEW YORK, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (NASDAQ: TLSA) ("Tiziana" or the "Company"), a clinical-stage biopharmaceutical company developing breakthrough therapies for KRAS+ Non-Small Cell Lung Cancer (NSCLC) and transformational drug delivery technologies to enable alternative routes of immunotherapy, today announced its Chief Executive Officer and Chief Scientific Officer, Kunwar Shailubhai, Ph.D., will participate in a virtual fireside chat at the B.Riley Securitie

  • GlobeNewswire

    Tiziana Life Sciences Ltd. To Implement Stock Repurchase Program for up to $5 Million

    NEW YORK, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd. (Nasdaq: TLSA) announced that its Board of Directors has today authorized the Company’s management to implement a stock repurchase program for up to $5 million of the Company’s common shares at any time. The term of the board authorization is until December 31, 2022. The repurchase program may be suspended or discontinued at any time and will be funded using the Company’s working capital. Executive Chairman Gabriele Cerrone c

  • GlobeNewswire

    Tiziana Life Sciences Announces Death of Director

    NEW YORK, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences (Nasdaq: TLSA) (“Tiziana”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, today announced that Dr. Thomas Adams passed away on January 9, 2022. He served as a member of Tiziana Life Science’s Board of Directors since February 2021. Dr. Kunwar Shailubhai, the Company's CEO, commented, "It is with great sadness that we announce the passing of Dr. Tom Adams. He was a highly valued Di